Latest Sexual intercourse Stories
GREENWOOD VILLAGE, Colo., Aug. 30, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that the manuscript reporting the results of its phase III clinical trials of Zertane(TM) for the treatment of the sexual dysfunction, premature ejaculation (PE), was accepted for publication in European Urology. Scientific Journal...
New research published by The Journal of Sexual Medicine has revealed how personal lifestyle choices, such as alcohol, recreational drugs and obesity are closely associated with erectile dysfunction. The growth of this socially taboo issue is leading to increased sales of counterfeit medication online. Self-diagnosis could damage your health, warns David Bailey, owner of Bury-based Medical Specialists online pharmacy. Bury, Lancashire (PRWEB) August 26, 2011 Research published by The...
Absorption Pharmaceuticals, makers of leading premature ejaculation solution PROMESCENT®, hires Ms. Harpreet Sheridan as vice president of sales. Ms. Sheridan comes to Absorption from GlaxoSmithKline, where she was a regional vice president of sales, focusing on male urology and sexual performance. Los Angeles, CA (PRWEB) August 24, 2011 Absorption Pharmaceuticals LLC (Absorption) is pleased to announce the hiring of Harpreet Sheridan as the vice president of sales. Ms. Sheridan...
RED BANK, N.J., Aug. 17, 2011 /PRNewswire/ -- A new HealthyWomen survey of postmenopausal women reveals that many of them are embarrassed to discuss the vaginal and sexual symptoms of menopause with their health care professional and with their partner. Among the survey respondents who did discuss their symptoms with their health care professional, over one quarter said they waited more than two years before doing so. Many of the postmenopausal women surveyed who had not spoken with their...
SAN DIEGO, Aug. 8, 2011 /PRNewswire/ -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq: APRI) announced today that it will file for market authorization to sell its erectile dysfunction drug, Vitaros(®), in Latin America. The Company also stated that it has engaged the services of Quintiles Global Regulatory Affairs, a leading international regulatory consultancy, to prepare its regulatory filings for Vitaros(®) for marketing approval in the following Latin American countries:...
Company's Viberect hand-held, non-pharmaceutical device to treat ED obtains FDA 510(k) clearance with support from Emergo Group Chambersburg, PA (PRWEB) July 23, 2011 Reflexonic, LLC, a Chambersburg, PA, based medical device technology developer specializing in urology, has achieved 510(k) clearance from the US Food and Drug Administration to market its non-pharmaceutical product to treat erectile dysfunction (ED), Viberectâ„¢. The Viberect device targets men with mild to...
A new study published in The Journal of Sexual Medicine reveals that several unhealthy lifestyle factors, such as weight problems, physical inactivity, high alcohol consumption, tobacco smoking, and hard drugs are associated with sexual dysfunctions in men. Additionally, an unhealthy lifestyle is more common in persons who are sexually inactive.Researchers led by Associate Professor Morten Frisch, MD, PhD, DSc, of Statens Serum Institut, used nationally representative survey data from 5,552...
GREENWOOD VILLAGE, Colo., June 27, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE - News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs") today announced results of its phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of two doses of Zertane(TM) for the treatment of premature ejaculation (PE). The study was conducted in 61...
The Oklahoma law firm of Atkins & Markoff and their team of defective drug lawyers hereby announces that it is offering free and confidential initial consultations for people who believe they are suffering from impotence and sexual dysfunction possibly due to Propecia use for hair loss. More information on whether or not a Propecia lawsuit can be filed may be found by visiting the newly added Propecia resource at http://www.atkinsandmarkoff.com (PRWEB) June 22, 2011 The Oklahoma law...
Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients, according to a study in the July issue of the urology journal BJUI.Researchers from Romania and the USA studied 17 heterosexual men and 12 homosexual men receiving a 50mg daily dose of bicalutamide, a fast-acting, non-steroidal anti-androgen, which is similar to other anti-androgens, but with reportedly fewer side effects.They discovered that...
